Learn about RECIST 1.1 and how it can be applied to your clinical trial.
RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.
Improved RECIST calculations which includes percent changes from Nadir.
User can enter Baseline and up to 9 follow up time points.
Target lesion measurements can be designated as lymph nodes.
- PAREXEL International Corporation
- 8 MB
- Requires iOS 8.0 or later. Compatible with iPhone 5s, iPhone 6, iPhone 6 Plus, iPhone 6s, iPhone 6s Plus, iPhone SE, iPhone 7, iPhone 7 Plus, iPhone 8, iPhone 8 Plus, iPhone X, iPhone XS, iPhone XS Max, iPhone XR, iPad Air, iPad Air Wi-Fi + Cellular, iPad mini 2, iPad mini 2 Wi-Fi + Cellular, iPad Air 2, iPad Air 2 Wi-Fi + Cellular, iPad mini 3, iPad mini 3 Wi-Fi + Cellular, iPad mini 4, iPad mini 4 Wi-Fi + Cellular, 12.9-inch iPad Pro, 12.9-inch iPad Pro Wi-Fi + Cellular, 9.7-inch iPad Pro, 9.7-inch iPad Pro Wi-Fi + Cellular, iPad (5th generation), iPad Wi-Fi + Cellular (5th generation), 12.9-inch iPad Pro (2nd generation), 12.9-inch iPad Pro Wi‑Fi + Cellular (2nd generation), 10.5-inch iPad Pro, 10.5-inch iPad Pro Wi‑Fi + Cellular, iPad (6th generation), iPad Wi-Fi + Cellular (6th generation), and iPod touch (6th generation).
- Age Rating
- Rated 12+ for the following:
- Infrequent/Mild Medical/Treatment Information
- © PAREXEL Informatics
With Family Sharing set up, up to six family members can use this app.